Rere | arginine glutamic acid dipeptide (RE) repeats
Physiological systems
19 / 24 physiological systems tested
3 Significantly impacted by the knock-out
Immune system Hematopoietic system Behavior/neurological
16 No significant impact
5 Not tested
Data collections
Viability data
Body weight measurements
Embryo imaging data
Body weight measurements
Embryo imaging data
Gene metrics:3Significant phenotypes
3Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased grip strength | 3 supporting datasets | RereRere | heterozygote | Early adult | 2.33x10-7 | ||
increased IgG2b level | 1 supporting dataset | RereRere | heterozygote | Early adult | 2.47x10-5 | ||
increased IgG1 level | 1 supporting dataset | RereRere | heterozygote | Early adult | 8.39x10-5 |
| | | | | | | | | |
External links
No external links available for Rere.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Reretm1e(EUCOMM)Wtsi | Targeted, non-conditional allele | | ES Cell |
Reretm297939(L1L2_Bact_P) | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector |
Reretm3a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Reretm3e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |